BALTIMORE--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, will report its financial results for the fourth quarter and full year ended December 31, 2006, on Monday, February 19th, 2007. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Cary J. Claiborne, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Tuesday, February 20, 2007, at 8:30 a.m. EST. To access the live webcast, please log on to the company's website at www.Osiris.com and go to the Investor Relations section. Alternatively, callers may participate in the conference call by dialing (800) 263-8506 (U.S. participants) or (719) 457-2681 (international participants).
